Achieve Life Sciences announces proposed public offering;...

2025-06-26 16:12:52 ET More on Achieve Life Sciences Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones Seeking Alpha's Quant Rating on Achieve Life Sciences Historical earnings data for Achieve Life Sciences Read the full article on Seeking Alpha For further details see: Achieve Life Sciences announces proposed public offering; shares down nearly 13%